How to Get NMN/NR (Nicotinamide Mononucleotide/Riboside) in Hawaii

NMN vs. NR: What Is Actually Available in Hawaii

Both nicotinamide mononucleotide (NMN) and nicotinamide riboside (NR) serve as precursors to nicotinamide adenine dinucleotide (NAD+), a coenzyme involved in over 500 enzymatic reactions tied to cellular energy metabolism and DNA repair 1. Their regulatory paths differ sharply, and that difference determines how you access each compound in Hawaii.

NMN: Prescription Compounding Only

In November 2022, the FDA excluded NMN from the dietary supplement definition under 21 U.S.C. § 321(ff)(3)(B), citing its prior investigation as a new drug by Metro International Biotech 2. This means NMN cannot be legally sold over the counter as a supplement in the United States. Hawaii residents who want pharmaceutical-grade NMN need a prescription filled through a licensed 503A compounding pharmacy.

NR: Available Over the Counter

NR retains its dietary supplement status. Products like Tru Niagen (nicotinamide riboside chloride, 300 mg) are sold in retail pharmacies and online without a prescription. Martens et al. Demonstrated that NR supplementation at 1,000 mg/day for six weeks was well tolerated in healthy older adults (N=24), with a 60% increase in whole-blood NAD+ levels compared to placebo 3.

Why Some Patients Choose Compounded NMN

Despite NR's accessibility, some clinicians and patients prefer NMN based on preclinical data suggesting more direct conversion to NAD+ through the nicotinamide phosphoribosyltransferase (NAMPT) pathway. Yoshino et al. (N=25 postmenopausal women with prediabetes) reported that 250 mg/day oral NMN for 10 weeks improved skeletal muscle insulin sensitivity by approximately 25% compared to placebo 1. The preference is not settled science. Both compounds raise NAD+, and head-to-head clinical trials comparing them in humans remain scarce.

Telehealth Prescribing for NMN in Hawaii

Hawaii law permits telehealth prescribing for NMN. The state adopted permanent telehealth parity legislation (Hawaii Revised Statutes §453-1.3 and §431:10A-116.3) that allows licensed providers to prescribe medications through audio-video consultations 4. A provider does not need to be physically located in Hawaii, but they must hold an active Hawaii medical license or be authorized through an interstate compact.

How a Typical Telehealth Visit Works

The process follows a predictable sequence. You complete a medical intake form that covers your health history, current medications, and goals for NAD+ support. A licensed provider (MD, DO, NP, or PA) reviews your intake, conducts a synchronous video consultation, and orders baseline labs if they have not been completed within the prior 90 days. If clinically appropriate, the provider writes a prescription and transmits it to a 503A compounding pharmacy.

Required Labs Before Prescribing

Most longevity-focused clinicians require a baseline panel before initiating NMN therapy. The standard workup includes a complete blood count (CBC), comprehensive metabolic panel (CMP), fasting lipid panel, and fasting glucose or HbA1c. Some providers also order intracellular NAD+ testing, though this assay is not universally standardized. Dr. Andrew Salzman, a physician-scientist who has studied NAD+ metabolism, has stated: "Measuring baseline NAD+ gives us a reference point, but the clinical decision to supplement should rest on the full metabolic picture, not a single biomarker" 5.

Follow-up labs are typically repeated at 8 to 12 weeks to assess response and safety markers, particularly liver enzymes (AST, ALT) and fasting glucose.

503A Compounding Pharmacies and Hawaii Shipping

Hawaii does not have a large number of local 503A compounding pharmacies that stock NMN. Most prescriptions are filled by mainland 503A pharmacies licensed to ship to Hawaii. Under federal law (the Drug Quality and Security Act of 2013), a 503A pharmacy may compound and dispense patient-specific prescriptions across state lines provided it holds the necessary state licenses 6.

Shipping Timelines

Expect 5 to 10 business days for delivery from mainland compounding pharmacies to Hawaiian addresses. NMN capsules and sublingual tablets do not require cold-chain shipping, which simplifies logistics. Some pharmacies offer expedited shipping at additional cost, reducing transit to 3 to 5 business days.

What to Verify Before Choosing a Pharmacy

Confirm that the pharmacy holds a valid Hawaii nonresident pharmacy license. Ask whether they use third-party testing (certificate of analysis) for potency and purity on each NMN batch. The Endocrine Society's 2019 clinical practice guidelines for hormone and supplement therapy recommend that compounded preparations "be obtained from pharmacies that voluntarily submit to third-party verification" 7.

Dosing, Forms, and What to Expect

Compounded NMN is most commonly dispensed as oral capsules (250 mg or 500 mg) or sublingual tablets. Sublingual delivery bypasses first-pass hepatic metabolism, which some clinicians believe improves bioavailability, though comparative pharmacokinetic data in humans is limited.

Starting and Maintenance Doses

A typical starting dose is 250 mg once daily, taken in the morning. After 4 to 8 weeks, providers may titrate upward to 500 mg or 1,000 mg daily depending on lab results and clinical response. Igarashi et al. Demonstrated in a randomized, placebo-controlled trial (N=31 healthy adults) that oral NMN at 250 mg/day for 12 weeks was safe and well tolerated, with no significant adverse events compared to placebo and measurable increases in blood NAD+ metabolites 5.

Timeline for Noticeable Effects

Most patients report subjective improvements in energy and sleep quality within 2 to 6 weeks. Objective lab changes (NAD+ levels, metabolic markers) typically require 8 to 12 weeks of consistent dosing. NMN is not a rapid-onset intervention. Patience and adherence matter more than dose escalation.

Side Effects

Reported side effects are generally mild. They include flushing, mild nausea, and transient headache. In the Yoshino et al. Trial, no serious adverse events were attributed to NMN at 250 mg/day over 10 weeks 1. Higher doses (above 1,000 mg/day) have less safety data, and most clinicians avoid exceeding this threshold without close monitoring.

Who Can Prescribe NMN in Hawaii

Hawaii permits MDs, DOs, nurse practitioners (NPs with prescriptive authority under HRS §457-8.6), and physician assistants (PAs under collaborative agreements) to prescribe compounded medications including NMN 8. NPs in Hawaii gained full practice authority in 2024, meaning they can prescribe independently without physician oversight for most medications.

Choosing the Right Provider Type

For straightforward NAD+ optimization in otherwise healthy adults, any of these provider types can manage the prescription. If you have complex comorbidities (e.g., active cancer, liver disease, or concurrent immunosuppressive therapy), an MD or DO with training in longevity medicine or endocrinology is preferable. The American Academy of Anti-Aging Medicine (A4M) maintains a directory of fellowship-trained providers, some of whom practice via telehealth and hold Hawaii licenses.

What Happens If You Move to Hawaii with an Existing Prescription

You cannot directly transfer a mainland NMN prescription to a Hawaii pharmacy the way you might transfer a standard retail prescription. Compounded medications require a new prescription from a provider licensed in Hawaii. If you relocate, schedule a telehealth visit with a Hawaii-licensed provider, bring your most recent lab results, and the provider can issue a new prescription to a 503A pharmacy that ships to your new address.

Insurance, Cost, and Medicaid Coverage in Hawaii

Hawaii Medicaid does not cover NMN. No major commercial insurer in Hawaii includes compounded NMN on its formulary. This is classified as a longevity or anti-aging intervention, and payers treat it as elective.

Out-of-Pocket Pricing

Compounded NMN typically costs between $60 and $180 per month depending on dose, form (capsule vs. Sublingual), and pharmacy. A 30-day supply of 500 mg daily capsules from a mainland 503A pharmacy averages around $90 to $120 before shipping. Sublingual formulations tend to run $20 to $40 higher per month due to added manufacturing steps.

Strategies to Reduce Cost

Some telehealth platforms offer bundled pricing that includes the provider consultation, lab order, and a 90-day NMN supply at a discount compared to purchasing each separately. Buying in 90-day quantities typically reduces the per-month cost by 15% to 25%. OTC nicotinamide riboside (NR) at 300 mg/day costs approximately $40 to $50 per month and may be a reasonable alternative for patients whose primary goal is raising NAD+ without a specific preference for NMN.

Prior Authorization and Documentation in Hawaii

Because NMN is not covered by Hawaii Medicaid or commercial plans, prior authorization is rarely relevant. If a patient attempts to submit a claim for compounded NMN, the insurer will almost certainly deny it. In the unlikely event that a plan does offer a path to coverage (e.g., through an employer-sponsored wellness benefit), the documentation typically required includes:

Standard Documentation for Any Prior Auth Attempt

A letter of medical necessity from the prescribing provider explaining the clinical rationale. Baseline lab results showing NAD+ deficiency or metabolic dysfunction. A record of the patient's diagnosis (ICD-10 codes such as E88.9 for metabolic disorder, unspecified, are sometimes used). Evidence that lower-cost alternatives (e.g., OTC NR) were tried or are contraindicated.

Dr. Charles Brenner, the biochemist who discovered NR as a vitamin precursor to NAD+, has noted: "The regulatory field for NAD+ precursors remains fragmented, with NMN and NR following very different paths despite serving similar biochemical functions" 3. That fragmentation is reflected in the insurance field as well.

Clinical Evidence Supporting NAD+ Precursor Use

The human evidence base for NMN and NR is growing but still early-stage. No large, multi-year randomized controlled trial has been completed for either compound.

Key NMN Trials

Yoshino et al. (2021, N=25) showed that 250 mg/day NMN improved muscle insulin signaling in postmenopausal women with prediabetes over 10 weeks 1. Igarashi et al. (2022, N=31) confirmed safety and tolerability of 250 mg/day NMN over 12 weeks in healthy adults, with increases in blood NAD+ metabolites 5. Yi et al. (2023, N=80) found that 600 mg or 1,200 mg/day NMN for 60 days increased blood NAD+ concentrations in a dose-dependent manner, with the 1,200 mg group showing a 38% increase over baseline 9.

Key NR Trials

Martens et al. (2018, N=24) demonstrated a 60% increase in whole-blood NAD+ with 1,000 mg/day NR over 6 weeks, alongside trends toward lower systolic blood pressure and reduced aortic stiffness 3. Dollerup et al. (2018, N=40 obese men) found that 2,000 mg/day NR for 12 weeks increased NAD+ but did not significantly improve insulin sensitivity in that population 10.

What the Evidence Does Not Yet Show

No trial has demonstrated that NMN or NR extends human lifespan. No trial has proven clinical superiority of one compound over the other. The strongest current evidence supports their safety and their ability to raise NAD+ levels. Whether raising NAD+ translates to meaningful clinical outcomes in healthy adults remains an open question that ongoing trials (including a Phase II study of NMN by Metro International Biotech) aim to answer.

Step-by-Step: Getting NMN in Hawaii

The process from initial consultation to receiving your first shipment involves five steps.

1. Select a telehealth provider. Choose a platform or clinician licensed in Hawaii who prescribes compounded NMN. Verify their medical license through the Hawaii Medical Board's online lookup.

2. Complete intake and labs. Fill out the medical history form. Get baseline bloodwork (CBC, CMP, lipid panel, fasting glucose) at any lab on Oahu, Maui, the Big Island, or Kauai. Quest Diagnostics and Labcorp both operate draw sites across the Hawaiian islands.

3. Attend the video consultation. The provider reviews your labs, discusses your goals, and determines whether NMN is appropriate.

4. Prescription transmitted to a 503A pharmacy. The provider sends the prescription electronically to a compounding pharmacy licensed to ship to Hawaii.

5. Receive your medication. Allow 5 to 10 business days for standard shipping. Confirm the package includes a certificate of analysis for the NMN batch.

Follow-up visits are typically scheduled every 3 to 6 months, with repeat labs at 8 to 12 weeks after initiation and then every 6 to 12 months on maintenance dosing.